On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...